About Jiabao
Jiabao is a company based in Beijing (China) founded in 2011 by Feng Tao. Jiabao has raised $14.35 million across 3 funding rounds from investors including Apricot Capital, ShenZhen GTJA Investment Group and Shanghai Life Insurance. Jiabao operates in a competitive market with competitors including Celmatix, Metabolomic Diagnostics, Ovation Fertility, NX Prenatal and LIA Diagnostics, among others.
- Headquarter Beijing, China
- Founders Feng Tao
- SectorsHealthcare
- Emailโขโขโขโขโขโขโขโข
- Phoneโขโขโขโข โขโขโขโข
- Website jabrehoo.com
- Social LinkedIn
- Total Equity Funding$14.35M (USD)
in 3 rounds
- Latest Funding Round$14.35M (USD), Series B
Aug 2020
- InvestorsApricot Capital
& 2 more
Funding Insights of Jiabao
Jiabao has successfully raised a total of $14.35M across 3 strategic funding rounds. The most recent funding activity was a Series B round of $14.35 million completed in August 2020. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $14.35M
- Total Rounds 3
- Last Round Series B โ $14.35M
- Investors Count 3
All 3 funding rounds of Jiabao with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Aug 2020 | $14.35M | Series B | โ | Apricot Capital | โ |
| Jun 2018 | – | Series B | โ | ShenZhen GTJA Investment Group | โ |
| Jun 2017 | – | Series B | โ | Shanghai Life Insurance | โ |
3 investors in total: 3 institutional.
Investors in Jiabao
Jiabao has secured backing from 3 investors, including venture fund and institutional investors. Prominent investors backing the company include Apricot Capital, ShenZhen GTJA Investment Group and Shanghai Life Insurance.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
- | – | apricot-capital.com | - | |
- | – | szgig.com | - | |
- | – | shanghailife.com.cn | - |
Investor details for Jiabao
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Jiabao
1 people are tracked at Jiabao (1 in leadership).
| Name | Role | Group |
|---|---|---|
Feng Tao | Co-Founder & CEO | Leadership |
Complete people profiles for Jiabao
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Jiabao
3 dated milestones of Jiabao across 9 years, from founding to its latest funding, stage changes and deals.
- Founded Jiabao is founded.
- Funding First funding round.
- Funding Latest funding round, Series B, of $14.3M.
Competitors of Jiabao
Jiabao operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Celmatix, Metabolomic Diagnostics, Ovation Fertility, NX Prenatal and LIA Diagnostics, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| celmatix.com | 2009 | New York, United States | $24.89M | 27 | Fertility decisions are optimized using data analytics and genomics. | |
| metabolomicdiagnostics.com | 2011 | Cork, Ireland | $3.89M | – | Diagnostics and prognostics for maternal health are developed using metabolomics. | |
| ovationfertility.com | 2016 | California, United States | – | – | Genetic diagnostics for fertility centers are offered through molecular testing. | |
| nxprenatal.com | 2010 | Louisville, United States | $5.76M | – | Early warning blood tests for pregnancy complications are provided. | |
| liadiagnostics.com | 2015 | Philadelphia, United States | $4.22M | – | Disposable paper pregnancy test kits | |
| confer.health | 2015 | Boston, United States | $9.5M | – | Clinical-grade diagnostic tests for home use are developed. | |
| adyn.com | 2019 | Seattle, United States | $2.65M | – | Provider of DNA and hormone analysis based birth control optimization kits | |
| genomicprediction.com | 2017 | North Brunswick, United States | $4.5M | – | Offers genomics tests to predict health outcomes for IVF procedures. |
Detailed competitors of Jiabao
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Jiabao
Complete news archive for Jiabao
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Similar companies to Jiabao
10 companies that operate in the same segment as Jiabao (Genomics & Gene Therapy Platforms), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
mRNA-based therapeutics for diseases including cancer and infections are developed. | 2010 | Cambridge, Massachusetts, United States | USD 2.78 B | USD 1.94 B | 5,800 | |
Digital sequencing technology for cancer detection is developed. | 2012 | Redwood City, California, United States | USD 557.5 M | USD 982.02 M | 2,020 | |
Circulating tumor DNA is screened for early cancer detection. | 2016 | Menlo Park, California, United States | USD 3.22 B | USD 147.17 M | 1,000 | |
Nanopore-based electronic systems for single-molecule analysis are developed. | 2005 | Oxford, Oxfordshire, United Kingdom | USD 1.3 B | USD 301.49 M | 1,480 | |
Provider of genetic test solutions to study ancestry, genealogy, and inherited traits | 2006 | Sunnyvale, California, United States | USD 943.53 M | USD 189.9 M | 265 | |
Provider of DNA testing services to create a family tree and ancestor | 2003 | Yehud, Central District, Israel | USD 40 M | – | – | |
Genetically modified cell lines are developed using AAV gene-editing platform. | 2007 | Cambridge, Cambridgeshire, United Kingdom | USD 46.29 M | – | – | |
Gene therapies for rare diseases including retinal dystrophies are developed. | 2013 | Philadelphia, Pennsylvania, United States | USD 82.8 M | USD 64.73 M | 822 | |
Therapeutics for genetic diseases are developed through targeted interventions. | 2015 | Palo Alto, California, United States | USD 434.2 M | USD 502.08 M | 730 | |
Provider of an online genealogy platform offering a host of services | 1996 | Lehi, Utah, United States | USD 146.2 M | – | – |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track โ from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Jiabao
Jiabao was founded in 2011 and raised its 1st funding round 6 years after it was founded.
Jiabao is headquartered in Beijing, China.
Feng Tao is the current CEO of Jiabao. They have also founded this company.
Jiabao is a funded company, having raised a total of $14.35M across 3 funding rounds to date.
Beijing Jiabao Renhe Medical Technology was founded in 2011 and is based in Beijing, China. Operations focus on the assisted reproduction sector, where genetic testing technologies for pre-pregnancy, pre-implantation screening and diagnosis, prenatal, and neonatal applications are provided. Equipment, consumables, diagnostics, and reagents are supplied, along with bioinformatics analysis platforms and sequencing systems.
Jiabao's top competitors include Celmatix, NX Prenatal and Metabolomic Diagnostics.
Jiabao has 3 investors. Key investors include Apricot Capital, ShenZhen GTJA Investment Group, and Shanghai Life Insurance.